Results 281 to 290 of about 112,151 (292)

Single inhaler extrafine triple therapy versus long-acting muscarinic antagonist therapy for chronic obstructive pulmonary disease (TRINITY): a double-blind, parallel group, randomised controlled trial

Lancet, The, 2017
Jørgen Vestbo, Alberto A Papi, Massimo Corradi   +2 more
exaly  

Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial

Lancet, The, 2016
Jyh-Ming Liou, Chieh-Chang Chen, Ming-Jong Bair   +2 more
exaly  

Chemoresistance Evolution in Triple-Negative Breast Cancer Delineated by Single-Cell Sequencing

Cell, 2018
Charissa R Kim, Ruli Gao, Johan Hartman
exaly  

Gravitational Perturbations in Exoplanetary Systems - Long periodic Perturbations in Eccentric Hierarchical Triple Systems

2010
Csizmadia, S, Borkovits, T
openaire   +3 more sources

Triple-negative breast cancer: disease entity or title of convenience?

Nature Reviews Clinical Oncology, 2010
Giuseppe Viale, David A Cameron, Luca Gianni   +2 more
exaly  

Sequential versus triple therapy for the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial

Lancet, The, 2013
Jyh-Ming Liou, Chieh-Chang Chen, Mei-Jyh Chen   +2 more
exaly  

Genomic and Transcriptomic Landscape of Triple-Negative Breast Cancers: Subtypes and Treatment Strategies

Cancer Cell, 2019
Yi-Zhou Jiang, Chen Suo, Xin Hu
exaly  

Extrafine inhaled triple therapy versus dual bronchodilator therapy in chronic obstructive pulmonary disease (TRIBUTE): a double-blind, parallel group, randomised controlled trial

Lancet, The, 2018
Alberto A Papi, Jørgen Vestbo, Massimo Corradi   +2 more
exaly  

Efficient calculation of the perturbational triples contributions in coupled cluster theory

AIP Conference Proceedings, 2015
Tomasz Janowski, Peter Pulay
openaire   +1 more source

Single inhaler triple therapy versus inhaled corticosteroid plus long-acting β2-agonist therapy for chronic obstructive pulmonary disease (TRILOGY): a double-blind, parallel group, randomised controlled trial

Lancet, The, 2016
Dave Singh, Alberto A Papi, Massimo Corradi   +2 more
exaly